Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors

被引：36

作者：

Alvarez-Roman, M. T. ^{[1
]}

Fernandez-Bello, I. ^{[1
]}

de la Corte-Rodriguez, H. ^{[1
]}

Hernandez-Moreno, A. L. ^{[1
]}

Martin-Salces, M. ^{[1
]}

Butta-Coll, N. ^{[1
]}

Rivas-Pollmar, M. I. ^{[1
]}

Rivas-Munoz, S. ^{[1
]}

Jimenez-Yuste, V. ^{[1
]}

机构：

[1] Univ Hosp, IdiPaz, Haematol Dept La Paz, Madrid, Spain

来源：

HAEMOPHILIA | 2017年 / 23卷 / 01期

关键词：

INDIVIDUALIZING PROPHYLAXIS;

D O I：

10.1111/hae.13141

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E50 / E54

页数：6

共 10 条

[1] Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A [J].

Bjorkman, S. .

HAEMOPHILIA, 2010, 16 (04) :597-605

[2] Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight [J].

Bjorkman, Sven ;

Oh, MyungShin ;

Spotts, Gerald ;

Schroth, Phillip ;

Fritsch, Sandor ;

Ewenstein, Bruce M. ;

Casey, Kathleen ;

Fischer, Kathelijn ;

Blanchette, Victor S. ;

Collins, Peter W. .

BLOOD, 2012, 119 (02) :612-618

[3] Association Between Physical Activity and Risk of Bleeding in Children With Hemophilia [J].

Broderick, Carolyn R. ;

Herbert, Robert D. ;

Latimer, Jane ;

Barnes, Chris ;

Curtin, Julie A. ;

Mathieu, Erin ;

Monagle, Paul ;

Brown, Simon A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (14) :1452-1459

[4] Break-through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A [J].

Collins, P. W. ;

Blanchette, V. S. ;

Fischer, K. ;

Bjorkman, S. ;

Oh, M. ;

Fritsch, S. ;

Schroth, P. ;

Spotts, G. ;

Astermark, J. ;

Ewenstein, B. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (03) :413-420

[5] Facilitating the implementation of pharmacokinetic-guided dosing of prophylaxis in haemophilia care by discrete choice experiment [J].

Lock, J. ;

De Bekker-Grob, E. W. ;

Urhan, G. ;

Peters, M. ;

Meijer, K. ;

Brons, P. ;

Van Der Meer, F. J. M. ;

Driessens, M. H. E. ;

Collins, P. W. ;

Fijnvandraat, K. ;

Leebeek, F. W. G. ;

Cnossen, M. H. .

HAEMOPHILIA, 2016, 22 (01) :E1-E10

[6] Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens [J].

Oldenburg, Johannes .

BLOOD, 2015, 125 (13) :2038-2044

[7] Individualizing prophylaxis in hemophilia: a review [J].

Petrini, Pia ;

Valentino, Leonard A. ;

Gringeri, Alessandro ;

Re, Wendy M. ;

Ewenstein, Bruce .

EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (02) :237-246

[8]

Reininger A, 2014, HAEMOPHILIA, V20, P15

[9] Guidelines for the management of hemophilia [J].

Srivastava, A. ;

Brewer, A. K. ;

Mauser-Bunschoten, E. P. ;

Key, N. S. ;

Kitchen, S. ;

Llinas, A. ;

Ludlam, C. A. ;

Mahlangu, J. N. ;

Mulder, K. ;

Poon, M. C. ;

Street, A. .

HAEMOPHILIA, 2013, 19 (01) :E1-E47

[10] Considerations in individualizing prophylaxis in patients with haemophilia A [J].

Valentino, L. A. .

HAEMOPHILIA, 2014, 20 (05) :607-615

← 1 →